BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10943818)

  • 1. What's new in human papillomavirus infection.
    Allen AL; Siegfried EC
    Curr Opin Pediatr; 2000 Aug; 12(4):365-9. PubMed ID: 10943818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of condyloma acuminata in the pediatric population.
    Culton DA; Morrell DS; Burkhart CN
    Pediatr Ann; 2009 Jul; 38(7):368-72. PubMed ID: 19685656
    [No Abstract]   [Full Text] [Related]  

  • 3. New treatments for genital warts less than ideal: abstract and commentary.
    Fife KH
    JAMA; 1998 Jun; 279(24):2003-4. PubMed ID: 9643868
    [No Abstract]   [Full Text] [Related]  

  • 4. Human papillomavirus-related genital disease in the immunocompromised host: Part II.
    Gormley RH; Kovarik CL
    J Am Acad Dermatol; 2012 Jun; 66(6):883.e1-17; quiz 899-900. PubMed ID: 22583721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts.
    Komericki P; Akkilic-Materna M; Strimitzer T; Aberer W
    Sex Transm Dis; 2011 Mar; 38(3):216-8. PubMed ID: 20938374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnosis and treatment of human papillomavirus-mediated genital lesions.
    Brodell LA; Mercurio MG; Brodell RT
    Cutis; 2007 Apr; 79(4 Suppl):5-10. PubMed ID: 17508490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for childhood warts.
    Dasher DA; Burkhart CN; Morrell DS
    Pediatr Ann; 2009 Jul; 38(7):373-9. PubMed ID: 19685657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients.
    Orlando G; Fasolo MM; Beretta R; Signori R; Adriani B; Zanchetta N; Cargnel A
    AIDS; 1999 Oct; 13(14):1978-80. PubMed ID: 10513659
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic approaches to genital warts.
    Beutner KR; Ferenczy A
    Am J Med; 1997 May; 102(5A):28-37. PubMed ID: 9217660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Consensus on HPV of the Portuguese Society of Andrology, Sexual Medicine and Reproduction: Treatment].
    Jorge Pereira B; Graça B; Palmas A; Eufrásio P; Lebre A; Andrade P; Louro N; Azinhais P; Cardoso P; Tomada N; Vendeira P
    Rev Int Androl; 2021; 19(3):150-159. PubMed ID: 32684426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local treatment of HPV-induced skin lesions by Cidofovir.
    Stragier I; Snoeck R; De Clercq E; Van Den Oord JJ; Van Ranst M; De Greef H
    J Med Virol; 2002 Jun; 67(2):241-5. PubMed ID: 11992585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.
    Snoeck R; Bossens M; Parent D; Delaere B; Degreef H; Van Ranst M; Noël JC; Wulfsohn MS; Rooney JF; Jaffe HS; De Clercq E
    Clin Infect Dis; 2001 Sep; 33(5):597-602. PubMed ID: 11477525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of warts].
    Suhonen R
    Duodecim; 2000; 116(15):1561-5. PubMed ID: 12001476
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of anogenital warts with topical cidofovir].
    Fernández-Morano T; Del Boz J; Frieyro-Elichegui M; Repiso JB; Padilla-España L; de Troya-Martín M
    Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):222-6. PubMed ID: 23182242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons.
    Matteelli A; Beltrame A; Graifemberghi S; Forleo MA; Gulletta M; Ciravolo G; Tedoldi S; Casalini C; Carosi G
    Sex Transm Dis; 2001 Jun; 28(6):343-6. PubMed ID: 11403192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large plantar wart caused by human papillomavirus-66 and resolution by topical cidofovir therapy.
    Davis MD; Gostout BS; McGovern RM; Persing DH; Schut RL; Pittelkow MR
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 2):340-3. PubMed ID: 10901717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical imiquimod: a review of its use in genital warts.
    Perry CM; Lamb HM
    Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of verruca vulgaris with topical cidofovir.
    Zabawski EJ; Sands B; Goetz D; Naylor M; Cockerell CJ
    JAMA; 1997 Oct; 278(15):1236. PubMed ID: 9333263
    [No Abstract]   [Full Text] [Related]  

  • 19. Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial).
    Murray ML; Meadows J; Doré CJ; Copas AJ; Haddow LJ; Lacey C; Jit M; Soldan K; Bennett K; Tetlow M; Nathan M; Gilson R
    BMC Med Res Methodol; 2018 Nov; 18(1):125. PubMed ID: 30400777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of human papillomavirus infection and associated epithelial tumors.
    Gross G
    Intervirology; 1997; 40(5-6):368-77. PubMed ID: 9675641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.